APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rhizoma Gastrodiae Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rhizoma Gastrodiae Tablets Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchRhizoma Gastrodiae Tablets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Rhizoma Gastrodiae Tablets Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Rhizoma Gastrodiae Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rhizoma Gastrodiae Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Rhizoma Gastrodiae Tablets Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Rhizoma Gastrodiae Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rhizoma Gastrodiae Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rhizoma Gastrodiae Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rhizoma Gastrodiae Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rhizoma Gastrodiae Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rhizoma Gastrodiae Tablets market include Zhaotong Huacheng Pharmaceutical, Taiji Group Sichuan Mianyang Pharmaceutical, Shaanxi Tianyang Pharmaceutical, Tsumura & Co., Lanzhou Foci Pharmaceutical, Guizhou Bailing, Guangxi Chanfang Pharmaceutical, Guangdong Luofushan National Pharmaceutical and Tongrentang Chinese Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rhizoma Gastrodiae Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rhizoma Gastrodiae Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rhizoma Gastrodiae Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rhizoma Gastrodiae Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Rhizoma Gastrodiae Tablets Segment by Company

Zhaotong Huacheng Pharmaceutical

Taiji Group Sichuan Mianyang Pharmaceutical

Shaanxi Tianyang Pharmaceutical

Tsumura & Co.

Lanzhou Foci Pharmaceutical

Guizhou Bailing

Guangxi Chanfang Pharmaceutical

Guangdong Luofushan National Pharmaceutical

Tongrentang Chinese Medicine

Rhizoma Gastrodiae Tablets Segment by Type

Gastrodia elata f.glauca

G.elata.BI.f elata

Other

Rhizoma Gastrodiae Tablets Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Rhizoma Gastrodiae Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Rhizoma Gastrodiae Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rhizoma Gastrodiae Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rhizoma Gastrodiae Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Rhizoma Gastrodiae Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rhizoma Gastrodiae Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rhizoma Gastrodiae Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rhizoma Gastrodiae Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rhizoma Gastrodiae Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rhizoma Gastrodiae Tablets industry.

Chapter 3: Detailed analysis of Rhizoma Gastrodiae Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rhizoma Gastrodiae Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rhizoma Gastrodiae Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rhizoma Gastrodiae Tablets Industry Trends Table 2. Rhizoma Gastrodiae Tablets Industry Drivers Table 3. Rhizoma Gastrodiae Tablets Industry Opportunities and Challenges Table 4. Rhizoma Gastrodiae Tablets Industry Restraints Table 5. Global Rhizoma Gastrodiae Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rhizoma Gastrodiae Tablets Revenue Share by Company (2021-2026) Table 7. Global Rhizoma Gastrodiae Tablets Sales Volume by Company (k units) & (2021-2026) Table 8. Global Rhizoma Gastrodiae Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Rhizoma Gastrodiae Tablets Average Price (US$/unit) of Company (2021-2026) Table 10. Global Rhizoma Gastrodiae Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rhizoma Gastrodiae Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Rhizoma Gastrodiae Tablets Company, Product Type & Application Table 13. Global Rhizoma Gastrodiae Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rhizoma Gastrodiae Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Gastrodia elata f.glauca Table 18. Significant Companies of G.elata.BI.f elata Table 19. Significant Companies of Other Table 20. Global Rhizoma Gastrodiae Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Rhizoma Gastrodiae Tablets Sales Volume by Type (2021-2026) & (k units) Table 22. Global Rhizoma Gastrodiae Tablets Sales Volume by Type (2027-2032) & (k units) Table 23. Global Rhizoma Gastrodiae Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Rhizoma Gastrodiae Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Rhizoma Gastrodiae Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Rhizoma Gastrodiae Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Rhizoma Gastrodiae Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Rhizoma Gastrodiae Tablets Sales Value Share by Type (2021-2026) Table 29. Global Rhizoma Gastrodiae Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Pharmacies Table 31. Significant Companies of Online Pharmacies Table 32. Significant Companies of Retail Pharmacies Table 33. Global Rhizoma Gastrodiae Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Rhizoma Gastrodiae Tablets Sales Volume by Application (2021-2026) & (k units) Table 35. Global Rhizoma Gastrodiae Tablets Sales Volume by Application (2027-2032) & (k units) Table 36. Global Rhizoma Gastrodiae Tablets Sales Volume Share by Application (2021-2026) Table 37. Global Rhizoma Gastrodiae Tablets Sales Volume Share by Application (2027-2032) Table 38. Global Rhizoma Gastrodiae Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Rhizoma Gastrodiae Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Rhizoma Gastrodiae Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Rhizoma Gastrodiae Tablets Sales Value Share by Application (2021-2026) Table 42. Global Rhizoma Gastrodiae Tablets Sales Value Share by Application (2027-2032) Table 43. Global Rhizoma Gastrodiae Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Rhizoma Gastrodiae Tablets Sales by Region (2021-2026) & (k units) Table 45. Global Rhizoma Gastrodiae Tablets Sales Market Share by Region (2021-2026) Table 46. Global Rhizoma Gastrodiae Tablets Sales by Region (2027-2032) & (k units) Table 47. Global Rhizoma Gastrodiae Tablets Sales Market Share by Region (2027-2032) Table 48. Global Rhizoma Gastrodiae Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Rhizoma Gastrodiae Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Rhizoma Gastrodiae Tablets Sales Value Share by Region (2021-2026) Table 51. Global Rhizoma Gastrodiae Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Rhizoma Gastrodiae Tablets Sales Value Share by Region (2027-2032) Table 53. Global Rhizoma Gastrodiae Tablets Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Rhizoma Gastrodiae Tablets Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Rhizoma Gastrodiae Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Rhizoma Gastrodiae Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Rhizoma Gastrodiae Tablets Sales by Country (2021-2026) & (k units) Table 58. Global Rhizoma Gastrodiae Tablets Sales Market Share by Country (2021-2026) Table 59. Global Rhizoma Gastrodiae Tablets Sales by Country (2027-2032) & (k units) Table 60. Global Rhizoma Gastrodiae Tablets Sales Market Share by Country (2027-2032) Table 61. Global Rhizoma Gastrodiae Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Rhizoma Gastrodiae Tablets Sales Value Market Share by Country (2021-2026) Table 63. Global Rhizoma Gastrodiae Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Rhizoma Gastrodiae Tablets Sales Value Market Share by Country (2027-2032) Table 65. Zhaotong Huacheng Pharmaceutical Company Information Table 66. Zhaotong Huacheng Pharmaceutical Business Overview Table 67. Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 69. Zhaotong Huacheng Pharmaceutical Recent Development Table 70. Taiji Group Sichuan Mianyang Pharmaceutical Company Information Table 71. Taiji Group Sichuan Mianyang Pharmaceutical Business Overview Table 72. Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 74. Taiji Group Sichuan Mianyang Pharmaceutical Recent Development Table 75. Shaanxi Tianyang Pharmaceutical Company Information Table 76. Shaanxi Tianyang Pharmaceutical Business Overview Table 77. Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 79. Shaanxi Tianyang Pharmaceutical Recent Development Table 80. Tsumura & Co. Company Information Table 81. Tsumura & Co. Business Overview Table 82. Tsumura & Co. Rhizoma Gastrodiae Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Tsumura & Co. Rhizoma Gastrodiae Tablets Product Portfolio Table 84. Tsumura & Co. Recent Development Table 85. Lanzhou Foci Pharmaceutical Company Information Table 86. Lanzhou Foci Pharmaceutical Business Overview Table 87. Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 89. Lanzhou Foci Pharmaceutical Recent Development Table 90. Guizhou Bailing Company Information Table 91. Guizhou Bailing Business Overview Table 92. Guizhou Bailing Rhizoma Gastrodiae Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Guizhou Bailing Rhizoma Gastrodiae Tablets Product Portfolio Table 94. Guizhou Bailing Recent Development Table 95. Guangxi Chanfang Pharmaceutical Company Information Table 96. Guangxi Chanfang Pharmaceutical Business Overview Table 97. Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 99. Guangxi Chanfang Pharmaceutical Recent Development Table 100. Guangdong Luofushan National Pharmaceutical Company Information Table 101. Guangdong Luofushan National Pharmaceutical Business Overview Table 102. Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio Table 104. Guangdong Luofushan National Pharmaceutical Recent Development Table 105. Tongrentang Chinese Medicine Company Information Table 106. Tongrentang Chinese Medicine Business Overview Table 107. Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Product Portfolio Table 109. Tongrentang Chinese Medicine Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Rhizoma Gastrodiae Tablets Distributors List Table 113. Rhizoma Gastrodiae Tablets Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Rhizoma Gastrodiae Tablets Product Image Figure 2. Global Rhizoma Gastrodiae Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rhizoma Gastrodiae Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rhizoma Gastrodiae Tablets Sales (2021-2032) & (k units) Figure 5. Global Rhizoma Gastrodiae Tablets Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Rhizoma Gastrodiae Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Gastrodia elata f.glauca Image Figure 10. G.elata.BI.f elata Image Figure 11. Other Image Figure 12. Global Rhizoma Gastrodiae Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Rhizoma Gastrodiae Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Rhizoma Gastrodiae Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Rhizoma Gastrodiae Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Rhizoma Gastrodiae Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Rhizoma Gastrodiae Tablets Sales Value Share by Type (2021-2032) Figure 18. Hospital Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Retail Pharmacies Image Figure 21. Global Rhizoma Gastrodiae Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Rhizoma Gastrodiae Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Rhizoma Gastrodiae Tablets Sales Volume Share by Application (2021-2032) Figure 24. Global Rhizoma Gastrodiae Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Rhizoma Gastrodiae Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Rhizoma Gastrodiae Tablets Sales Value Share by Application (2021-2032) Figure 27. Global Rhizoma Gastrodiae Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Rhizoma Gastrodiae Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Rhizoma Gastrodiae Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Rhizoma Gastrodiae Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Rhizoma Gastrodiae Tablets Sales Value (2021-2032) & (US$ Million) Figure 32. North America Rhizoma Gastrodiae Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Rhizoma Gastrodiae Tablets Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Rhizoma Gastrodiae Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Rhizoma Gastrodiae Tablets Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Rhizoma Gastrodiae Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Rhizoma Gastrodiae Tablets Sales Value (2021-2032) & (US$ Million) Figure 38. South America Rhizoma Gastrodiae Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Rhizoma Gastrodiae Tablets Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Rhizoma Gastrodiae Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Rhizoma Gastrodiae Tablets Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Rhizoma Gastrodiae Tablets Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Gastrodia elata f.glauca
  • G.elata.BI.f elata
  • Other
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Zhaotong Huacheng Pharmaceutical
  • Taiji Group Sichuan Mianyang Pharmaceutical
  • Shaanxi Tianyang Pharmaceutical
  • Tsumura & Co.
  • Lanzhou Foci Pharmaceutical
  • Guizhou Bailing
  • Guangxi Chanfang Pharmaceutical
  • Guangdong Luofushan National Pharmaceutical
  • Tongrentang Chinese Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rhizoma Gastrodiae Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Rhizoma Gastrodiae Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Rhizoma Gastrodiae Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rhizoma Gastrodiae Tablets Market Dynamics
  1. 2.1 Rhizoma Gastrodiae Tablets Industry Trends
  2. 2.2 Rhizoma Gastrodiae Tablets Industry Drivers
  3. 2.3 Rhizoma Gastrodiae Tablets Industry Opportunities and Challenges
  4. 2.4 Rhizoma Gastrodiae Tablets Industry Restraints
3 Rhizoma Gastrodiae Tablets Market by Company
  1. 3.1 Global Rhizoma Gastrodiae Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Rhizoma Gastrodiae Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Rhizoma Gastrodiae Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Rhizoma Gastrodiae Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Rhizoma Gastrodiae Tablets Company Ranking (2024-2026)
  6. 3.6 Global Rhizoma Gastrodiae Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Rhizoma Gastrodiae Tablets Company Product Type and Application
  8. 3.8 Global Rhizoma Gastrodiae Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rhizoma Gastrodiae Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rhizoma Gastrodiae Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rhizoma Gastrodiae Tablets Market by Type
  1. 4.1 Rhizoma Gastrodiae Tablets Type Introduction
  2. 4.1.1 Gastrodia elata f.glauca
  3. 4.1.2 G.elata.BI.f elata
  4. 4.1.3 Other
  5. 4.2 Global Rhizoma Gastrodiae Tablets Sales Volume by Type
  6. 4.2.1 Global Rhizoma Gastrodiae Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Rhizoma Gastrodiae Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Rhizoma Gastrodiae Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Rhizoma Gastrodiae Tablets Sales Value by Type
  10. 4.3.1 Global Rhizoma Gastrodiae Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Rhizoma Gastrodiae Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Rhizoma Gastrodiae Tablets Sales Value Share by Type (2021-2032)
5 Rhizoma Gastrodiae Tablets Market by Application
  1. 5.1 Rhizoma Gastrodiae Tablets Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Rhizoma Gastrodiae Tablets Sales Volume by Application
  6. 5.2.1 Global Rhizoma Gastrodiae Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rhizoma Gastrodiae Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Rhizoma Gastrodiae Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Rhizoma Gastrodiae Tablets Sales Value by Application
  10. 5.3.1 Global Rhizoma Gastrodiae Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rhizoma Gastrodiae Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Rhizoma Gastrodiae Tablets Sales Value Share by Application (2021-2032)
6 Rhizoma Gastrodiae Tablets Regional Sales and Value Analysis
  1. 6.1 Global Rhizoma Gastrodiae Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rhizoma Gastrodiae Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Rhizoma Gastrodiae Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Rhizoma Gastrodiae Tablets Sales by Region (2027-2032)
  5. 6.3 Global Rhizoma Gastrodiae Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rhizoma Gastrodiae Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rhizoma Gastrodiae Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rhizoma Gastrodiae Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Rhizoma Gastrodiae Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rhizoma Gastrodiae Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Rhizoma Gastrodiae Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rhizoma Gastrodiae Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Rhizoma Gastrodiae Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rhizoma Gastrodiae Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rhizoma Gastrodiae Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rhizoma Gastrodiae Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Rhizoma Gastrodiae Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rhizoma Gastrodiae Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rhizoma Gastrodiae Tablets Sales Value Share by Country, 2025 VS 2032
7 Rhizoma Gastrodiae Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Rhizoma Gastrodiae Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rhizoma Gastrodiae Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rhizoma Gastrodiae Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Rhizoma Gastrodiae Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Rhizoma Gastrodiae Tablets Sales by Country (2027-2032)
  6. 7.4 Global Rhizoma Gastrodiae Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rhizoma Gastrodiae Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rhizoma Gastrodiae Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rhizoma Gastrodiae Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rhizoma Gastrodiae Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rhizoma Gastrodiae Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhaotong Huacheng Pharmaceutical
  2. 8.1.1 Zhaotong Huacheng Pharmaceutical Company Information
  3. 8.1.2 Zhaotong Huacheng Pharmaceutical Business Overview
  4. 8.1.3 Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhaotong Huacheng Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  6. 8.1.5 Zhaotong Huacheng Pharmaceutical Recent Developments
  7. 8.2 Taiji Group Sichuan Mianyang Pharmaceutical
  8. 8.2.1 Taiji Group Sichuan Mianyang Pharmaceutical Company Information
  9. 8.2.2 Taiji Group Sichuan Mianyang Pharmaceutical Business Overview
  10. 8.2.3 Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Taiji Group Sichuan Mianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  12. 8.2.5 Taiji Group Sichuan Mianyang Pharmaceutical Recent Developments
  13. 8.3 Shaanxi Tianyang Pharmaceutical
  14. 8.3.1 Shaanxi Tianyang Pharmaceutical Company Information
  15. 8.3.2 Shaanxi Tianyang Pharmaceutical Business Overview
  16. 8.3.3 Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shaanxi Tianyang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  18. 8.3.5 Shaanxi Tianyang Pharmaceutical Recent Developments
  19. 8.4 Tsumura & Co.
  20. 8.4.1 Tsumura & Co. Company Information
  21. 8.4.2 Tsumura & Co. Business Overview
  22. 8.4.3 Tsumura & Co. Rhizoma Gastrodiae Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tsumura & Co. Rhizoma Gastrodiae Tablets Product Portfolio
  24. 8.4.5 Tsumura & Co. Recent Developments
  25. 8.5 Lanzhou Foci Pharmaceutical
  26. 8.5.1 Lanzhou Foci Pharmaceutical Company Information
  27. 8.5.2 Lanzhou Foci Pharmaceutical Business Overview
  28. 8.5.3 Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lanzhou Foci Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  30. 8.5.5 Lanzhou Foci Pharmaceutical Recent Developments
  31. 8.6 Guizhou Bailing
  32. 8.6.1 Guizhou Bailing Company Information
  33. 8.6.2 Guizhou Bailing Business Overview
  34. 8.6.3 Guizhou Bailing Rhizoma Gastrodiae Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guizhou Bailing Rhizoma Gastrodiae Tablets Product Portfolio
  36. 8.6.5 Guizhou Bailing Recent Developments
  37. 8.7 Guangxi Chanfang Pharmaceutical
  38. 8.7.1 Guangxi Chanfang Pharmaceutical Company Information
  39. 8.7.2 Guangxi Chanfang Pharmaceutical Business Overview
  40. 8.7.3 Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Guangxi Chanfang Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  42. 8.7.5 Guangxi Chanfang Pharmaceutical Recent Developments
  43. 8.8 Guangdong Luofushan National Pharmaceutical
  44. 8.8.1 Guangdong Luofushan National Pharmaceutical Company Information
  45. 8.8.2 Guangdong Luofushan National Pharmaceutical Business Overview
  46. 8.8.3 Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Guangdong Luofushan National Pharmaceutical Rhizoma Gastrodiae Tablets Product Portfolio
  48. 8.8.5 Guangdong Luofushan National Pharmaceutical Recent Developments
  49. 8.9 Tongrentang Chinese Medicine
  50. 8.9.1 Tongrentang Chinese Medicine Company Information
  51. 8.9.2 Tongrentang Chinese Medicine Business Overview
  52. 8.9.3 Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Tongrentang Chinese Medicine Rhizoma Gastrodiae Tablets Product Portfolio
  54. 8.9.5 Tongrentang Chinese Medicine Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rhizoma Gastrodiae Tablets Value Chain Analysis
  2. 9.1.1 Rhizoma Gastrodiae Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rhizoma Gastrodiae Tablets Sales Mode & Process
  6. 9.2 Rhizoma Gastrodiae Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rhizoma Gastrodiae Tablets Distributors
  9. 9.2.3 Rhizoma Gastrodiae Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst